Point Of Contact Not Available

Award Info Published Friday March 13, 2015 Awarded to: Vendor: Becton, Dickinson & Co (BD), Franklin Lakes, NJ Amount: An estimated $140,000 Terms: One-time transaction The University award process may be delayed up to thirty days as this award goes through a state approval process. The hearing has been cancelled Published Monday March 9, 2015 The hearing has been cancelled since no vendors registered to attend or submitted comments regarding this notice. First published Monday, February 23, 2015 The University awarded a contract for Becton, Dickinson's (BD) FACSCanto II instrument. to Becton, Dickinson & Co (BD), Franklin Lakes, NJ, for an estimated $140,000. Purchase the Becton, Dickinson's (BD) FACSCanto II instrument. The FACSCanto II is the only digital 6 color IVD cleared platform capable of running the IVD cleared Stem Cell Enumeration kit. The FACSCanto II is also the only instrument that can be field upgraded to an 8 color system and maintain the IVD clearance for the Stem Cell Enumeration assay that is required for Stem Cell Transplant Labs.Having additional “colors” allows you to evaluate the patient using less sample. In Stem Cell Enumeration for bone marrow transplant, it’s important to use as little patient sample as possible so that the majority of the cells can be used for the bone marrow transplant following chemotherapy. Future testing of other cell populations (Mesenchymal stem cells, for example) is supported with this technology. BD's Trucount technology allows for single platform absolute counts (all information from one instrument—no need for hematology counts to determine total cell numbers) and is considered the gold standard. No other platform provides the lyophilized counting beads which eliminates pipetting errors and provides for a more accurate result. Absolute counts refers to the number of cells per volume of sample. When evaluating apheresis products, it is imperative to accurately quantify the number of cells as this determines if there is a sufficient number of stem cells to rescue the patient after ablative chemotherapy. Prior to putting a patient on apheresis to harvest mobilized stem cells, it is also necessary to evaluate if they have a sufficient number of these cells to warrant the procedure. The University has determined that this purchase is only economically available from this source because the item or service is copyrighted or patented and is not available except from the holder of the copyright or patent. For additional information, contact: John Meehan University of Ilinois at Chicago Purchasing Division (M/C 560) 809 South Marshfield Avenue Chicago, IL 60612-7203 Phone: (312) 413-5961 FAX: (312) 996-2055 Purchasing Website State Purchasing Officer - Aaron M. Finder We will hold a public hearing at the date, time and location specified below, if we receive a request to testify regarding the sole source determination. We will also hold a hearing if any vendor submits a signed statement showing the capability to provide the stated supplies/services at or below the amount indicated. The public hearing allows any interested party the opportunity to testify for or against the sole source determination as described in this notice. The purpose of the hearing is to receive information from the public in a reasonable manner. Formal rules of evidence will not apply. The hearing officer will produce minutes of the hearing and may record it in order to aid in the production of the minutes. After conclusion of the hearing we will decide whether the sole source determination was appropriate. We must receive any request to testify and any vendor statement no later than the registration date and time indicated below. If we do not receive a timely request or statement, we will not hold the hearing. We reserve the right to cancel the procurement prior to any scheduled hearing. Please confirm the status of the hearing with the Hearing Contact. Hearing Details Date: March 11, 2015 Time: 2:00 PM Location: Stratton Building Room 511 401 S. Spring Street Springfield, IL If you cannot attend the meeting in-person at the primary location, you may attend via audio or video conference, as available, at one of the optional locations. Alternate Location(s): James R. Thompson Center Room 9-036 100 West Randolph Chicago, IL Hearing Contact: Aaron M. Finder Phone:(217) 558-3050 Fax:(217) 558-5407 E-mail:[email protected] Date, time, and location are subject to change and/or cancellation. It is the responsibility of potential participants to confirm these details prior to attendance. Registration Registration Deadline: March 6, 2015 Register with: Aaron M. Finder Phone:(217) 558-3050 Fax:(217) 558-5407 E-mail:[email protected]

Bid Protests Not Available